Tuttiquotidiani is completely free. Every day we aggregate news from 100+ sources and generate original AI summaries for you. Help us keep the service running with a small donation, or become TQ Pro for just €1/month.

Donate now TQ Pro - 1€/mo
  1. Home

Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss

  • Posted on June 9, 2026
  • By Wired
  • 0 Views
  • 1 min read
Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss
Longevity Startup Doses First Human in Bid to Reverse Age-Related Sight Loss

It'll be the first time ER-100 technology they claim can reverse aging in cells has been tested on a human.
continue reading...

Author
Wired

You May Also Like